Skip to main content

Table 6 Occurrence of antimicrobial resistance among Escherichia coli isolated from cattle suffering from either diarrhoea or mastitis in different European countries.

From: Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002–2004

Antimicrobial agent

Year

Country and prevalence of resistance

  

B

DK

E

F

I

LV

ES

NL

S

CH

Origin

 

Diarrhoea

Mastitis

Ampicillin

2002

63.7

79.0

44.0

76.1

44.0

-

45.6

13.3

-

-

 

2003

64.0

75.4

49.0

76.0

41.0

67.0

45.5

18.8

7.0

33.5

 

2004

75.5

72.1

53.0

-

25.0

-

51.0

13.9

29.0

0.0

Amoxicillin + Clavulanic acid

2002

47.0

-

14.0

30.0

14.0

-

10.3

1.0

-

-

 

2003

16.0

3.5

19.0

34.0

6.0

54.0

4.5

1.0

-

0.0

 

2004

10.1

1.2

19.0

-

7.4

-

9.0

0.0

-

0.0

Apramycin

2002

10.8

0.0

3.0

17.2

-

-

3.7

-

-

-

 

2003

10.0

3.6

3.0

11.0

-

-

5.2

-

0.0

-

 

2004

8.0

0.0

3.0

-

-

-

6.0

-

-

-

Ceftiofur

2002

0.0

0.0

-

1.2

-

-

5.9a

0.0

-

-

 

2003

2.0

0.0

-

0,7

-

0.0

2.6a

0.0

0.0

0.0

 

2004

6.3

0.0

-

-

7.1

-

6.0a

0.0

0.0

-

Chloramphenicol

2002

54.9

13.0

-

65.4

30.0

-

29.4

-

-

-

 

2003

48.0

14.1

-

58.0

21.0

-

33.8

-

2.0

18.0

 

2004

52.7

22.8

-

-

-

-

31.0

-

5.0

13.3

Fluoroquinolones

2002

35.3

1.0

0.1

31.2

22.0

-

11.8

0.0

-

-

 

2003

26.0

1.8

0.04

20.0

15.0

0.0

12.3

0.0

1.0

6.0

 

2004

32.1

7.6

0.0

-

11.5

-

20.0

1.0

10.0

0.0

Florfenicol

2002

31.4

1.0

-

12.6

-

-

8.1

-

-

-

 

2003

26.0

3.5

-

12.0

-

-

9.7

-

0.0

-

 

2004

21.5

5.1

-

-

-

-

8.0

-

0.0

-

Gentamicin

2002

53.3

1.0

-

21.6

12.0

-

14.0

0.0

-

-

 

2003

16.0

3.6

-

20.0

1.0

29.0

19.5

0.0

0.0

6.0

 

2004

7.6

7.6

-

-

7.1

-

25.0

0.0

0.0

6.7

Nalidixic acid

2002

42.2

19.0

-

35.0

30.0

-

21.3

1.0

-

-

 

2003

38.0

14.1

-

36.0

21.0

56.0

18.8

-

3.0

-

 

2004

54.0

29.1

-

-

21.4

-

31.0

-

14.0

-

Neomycin

2002

46.0

9.0

26.0

42.5

-

-

25.0

7.6

-

-

 

2003

26.0

15.8

27.0

44.0

-

86.0

25.0

6.9

1.0

18.0

 

2004

17.7

45.6

30.0

-

-

-

26.0

5.0

7.0

-

Streptomycin

2002

-

70.0

-

78.6

24.0

-

52.2

15.2

-

-

 

2003

-

68.4

-

78.0

54.0

69.0

54.8

20.8

11.0

-

 

2004

-

87.3

-

-

25.0

-

55.0

15.8

48.0

-

Sulphonamides

2002

-

74.0

-

80.6

46.0

-

45.6

-

-

-

 

2003

-

65.0

-

69.0

47.0

100.0

52.9

-

8.0

-

 

2004

-

94.9

-

-

25.0

-

51.0

-

41.0

-

Tetracycline

2002

58.8

84.0

48.0

79.5

56.0

-

49.3

14.3

-

-

 

2003

64.0

75.5

52.0

76.0

52.0

71.0

56.5

20.8

5.0

24.0

 

2004

76.4

84.8

57.0

-

28.6

-

59.0

14.9

37.0

20.0

Trimethoprim

2002

-

54.0

-

52.4

-

-

33,1

-

-

-

 

2003

-

52.6

-

39.0

-

0.0

41.9

-

3.0

-

 

2004

-

70.9

-

-

-

-

41.0

-

10.0

-

TMP + Sulphonamide

2002

56.9

-

23.0

39.5

26.0

-

-

11.4

-

-

 

2003

44.0

-

27.0

35.0

24.0

0.0

-

10.9

-

12.5

 

2004

54.0

-

28.0

-

8.7

-

-

8.9

-

-

  1. a: Cefotaxime
  2. B – Belgium; DK – Denmark; E – England; F – France; I – Italy; LV – Latvia; NL – The Netherlands; ES – Spain; S – Sweden; CH – Switzerland.